Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

References

• Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000; 6: 142–50
   PubMed Web of Science ®Google Scholar
• Oldenburg B, Koningsberger JC, Berge Henegouwen GP, van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 429–38
   PubMed Web of Science ®Google Scholar
• Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53: 1190–7
   PubMed Web of Science ®Google Scholar
• Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon?. Pharmacol Ther 1992; 53: 375–408
   PubMed Web of Science ®Google Scholar
• Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001; 15: 1989–99
   PubMed Web of Science ®Google Scholar
• Oldenburg B, Berge Henegouwen GP, Rennick D, van Asbeck BS, Koningsberger JC. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000; 30: 505–10
   PubMed Web of Science ®Google Scholar
• Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol 2004; 39: 514–9
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002; 47: 1266–78
   PubMed Web of Science ®Google Scholar
• Geisser P, Baer M, Schaub E. Structure/histotoxicity relationship of parenteral iron preparations. Arzneimittelforschung 1992; 42: 1439–52
   PubMed Web of Science ®Google Scholar
• Bodemar G, Kechagias S, Almer S, Danielson BG. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 2004; 39: 454–8
   PubMed Web of Science ®Google Scholar
• Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997; 126: 782–7
   PubMed Web of Science ®Google Scholar
• Gasche C, Dejaco C, Reinisch W, Tillinger W, Waldhoer T, Fueger GF, et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999; 60: 262–7
   PubMed Web of Science ®Google Scholar
• Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001; 96: 2382–7
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43: 29–32
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439–44
   PubMed Web of Science ®Google Scholar
• Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57: 715S–24S
   PubMed Web of Science ®Google Scholar
• Svardal AM, Mansoor MA, Ueland PM. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 1990; 184: 338–46
   PubMed Web of Science ®Google Scholar
• Vaagenes H, Muna ZA, Madsen L, Berge RK. Low doses of eicosapentaenoic acid, docosahexaenoic acid, and hypolipidemic eicosapentaenoic acid derivatives have no effect on lipid peroxidation in plasma. Lipids 1998; 33: 1131–7
   PubMed Web of Science ®Google Scholar
• Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 1991; 572: 103–16
   PubMed Web of Science ®Google Scholar
• Johne B, Kronborg O, Ton HI, Kristinsson J, Fuglerud P. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 2001; 36: 291–6
   PubMed Web of Science ®Google Scholar
• Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003; 38: 543–8
   PubMed Web of Science ®Google Scholar
• De Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003; 9: 316–20
   PubMed Web of Science ®Google Scholar
• De Silva AD, Rampton DS. Tolerance and efficacy of oral iron therapy in patients with and without inflammatory bowel disease. Gut 2003; 52(Suppl VI)A111
   Google Scholar
• Erichsen K, Gudbrandsen O, Arslan G, Milde A, Helgeland L, Ulvik RJ, et al. Effect of ferrous fumarate supplementation in dextran sulfate sodium colitis in rats. Gut 2003; 52(Suppl VI)A28
   PubMed Web of Science ®Google Scholar
• Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, et al. Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol 1999; 104: 296–302
   PubMed Web of Science ®Google Scholar
• Esposito BP, Breuer W, Slotki I, Cabantchik ZI. Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur J Clin Invest 2002; 32 Suppl 1: 42–9
   PubMed Web of Science ®Google Scholar
• Van Wyck D, Anderson J, Johnson K. Labile iron in parenteral iron formulations: a quantitative and comparative study. Nephrol Dial Transplant 2004; 19: 561–5
   PubMed Web of Science ®Google Scholar
• Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 2000; 23: 185–92
   PubMedGoogle Scholar
• Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002; 32 Suppl 1: 50–4
   PubMed Web of Science ®Google Scholar
• Kooistra MP, Kersting S, Gosriwatana I, Lu S, Nijhoff-Schutte J, Hider RC, et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. Eur J Clin Invest 2002; 32 Suppl 1: 36–41
   PubMed Web of Science ®Google Scholar
• Parkkinen J, von Bonsdorff L, Peltonen S, Gronhagen-Riska C, Rosenlof K. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant 2000; 15: 1827–34
   PubMed Web of Science ®Google Scholar
• Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11: 539–49
   PubMed Web of Science ®Google Scholar
• Agarwal R, Vasavada N, Sachs NG, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 2004; 65: 2279–89
   PubMed Web of Science ®Google Scholar
• Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 1999; 14: 2680–7
   PubMed Web of Science ®Google Scholar
• Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 2002; 32 Suppl 1: 9–16
   PubMed Web of Science ®Google Scholar
• Tovbin D, Mazor D, Vorobiov M, Chaimovitz C, Meyerstein N. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am J Kidney Dis 2002; 40: 1005–12
   PubMed Web of Science ®Google Scholar